Portland-based MaineHealth has named Richard Bayman its next CFO. Mr. Bayman will begin the role in January, according to a Dec. 12 MaineHealth news release shared with Becker's. He succeeds Albert ...

Salt Lake City-based Intermountain Health's St. Mary's Regional Hospital in Grand Junction, Colo., recently became the first community hospital in the nation to receive vascular verification from the ...

1. Eighteen percent of female physicians said "yes" when asked whether they think their employer prioritizes their career growth, while 46% said "no" and 36% said they were unsure. 2. Sixty-seven ...

Elise MacCarroll-Wright has been named president and CEO of UChicago Medicine AdventHealth Hinsdale (Ill.), effective Jan. 6. Ms. MacCarroll-Wright currently serves as corporate vice president of ...

Publicly traded for-profit health systems have sold dozens of hospitals in 2024 and academic health systems are among those acquiring the facilities.

Meet Zach Yoder, the newly appointed president of OSF HealthCare St. Anthony's Health Center in Alton, IL. Learn about his impressive accomplishments and exper ...

Discover how St. Luke's Hospital president and CEO Andrew Bagnall is tackling healthcare industry challenges and strategically improving patient care.

Vineland, N.J.-based Inspira Health reported a $51.6 million operating loss (-5.2% margin) in the third quarter of 2024, falling from a $31.6 million operating loss (-3.4% margin) during the same ...

For its 2024 "Nurse Career Satisfaction Report," Medscape surveyed 7,723 practicing U.S. nurses between March 20 and June 26.

Sean Kamber was named CEO of HCA Healthcare's Menorah Medical Center in Overland Park, Kan., according to a Dec. 12 news release shared with Becker's. Mr. Kamber brings nearly 15 years of executive ...

President-elect Donald Trump is set to appoint Andrew Ferguson as chair of the Federal Trade Commission, according to a Dec. 10 Truth Social post. "Andrew has a proven record of standing up to big ...

The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from ...